Protide Pharmaceuticals Inc (PPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2003 | 08-2002 | 08-2001 | 08-2000 | 08-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110 | 200 | 190 | 60 | N/A |
| Marketable Securities | 80 | 80 | 210 | 560 | N/A |
| Receivables | 40 | 30 | 20 | 30 | N/A |
| Inventories | 50 | 50 | 50 | 50 | 50 |
| Other current assets | 20 | 10 | 20 | 30 | 10 |
| TOTAL | $300 | $370 | $490 | $730 | $60 |
| Non-Current Assets | |||||
| PPE Net | 20 | 40 | 70 | 100 | 130 |
| Other Non-Current Assets | 40 | 40 | 40 | 50 | 50 |
| TOTAL | $60 | $80 | $110 | $150 | $180 |
| Total Assets | $360 | $470 | $620 | $880 | $240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 10 | 10 | 7 | 10 |
| Accrued Expenses | 20 | 20 | 30 | 30 | 20 |
| Other current liabilities | 0 | 5 | 20 | 0 | 0 |
| TOTAL | $110 | $120 | $130 | $110 | $100 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $110 | $120 | $130 | $110 | $100 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | 30 | 30 | 20 |
| Retained earnings | -5,620 | -5,520 | -5,320 | -4,950 | N/A |
| Other shareholders' equity | 0 | -10 | 10 | 0 | 0 |
| TOTAL | $250 | $340 | $480 | $770 | $5,330 |
| Total Liabilities And Equity | $360 | $460 | $610 | $880 | $5,430 |